Andrew Cheng

President and CEO

Andrew Cheng (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in AKRO. The largest single filing was $1.6M of AKRO (30,000 sh × $53.98, as filed), executed Oct 10 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.6M

shares × price, as filed

Last traded

Oct 10 2025

Filed Oct 14 2025

Open performance→

Volume by month

Buys $0 Sells $22.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names

AKRO AKRO AKRO · 0 buys · 15 sells 15 filings

Recent filings

AKROSALE Akero Therapeutics, Inc. View filing → $1.2M
28,784 sh × $41.75
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $1.5M
29,051 sh across 3 lots
Exec Feb 10 2025
Filed Feb 11 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $1.6M
30,000 sh across 3 lots
Exec Jan 27 2025
Filed Jan 29 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $242K
7,855 sh × $30.79
Exec Dec 10 2024
Filed Dec 12 2024 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $802K
25,000 sh × $32.09
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $3.4M
108,366 sh across 2 lots
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $2.8M
88,305 sh across 2 lots
Exec Oct 16 2024
Filed Oct 18 2024 · 5:30 PM ET